BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36867864)

  • 21. Single siRNA Nanocapsules for Effective siRNA Brain Delivery and Glioblastoma Treatment.
    Zou Y; Sun X; Wang Y; Yan C; Liu Y; Li J; Zhang D; Zheng M; Chung RS; Shi B
    Adv Mater; 2020 Jun; 32(24):e2000416. PubMed ID: 32374446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein E Peptide-Directed Chimeric Polymersomes Mediate an Ultrahigh-Efficiency Targeted Protein Therapy for Glioblastoma.
    Jiang Y; Zhang J; Meng F; Zhong Z
    ACS Nano; 2018 Nov; 12(11):11070-11079. PubMed ID: 30395440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual functional nanoparticles efficiently across the blood-brain barrier to combat glioblastoma
    Jin Z; Piao L; Sun G; Lv C; Jing Y; Jin R
    J Drug Target; 2021 Mar; 29(3):323-335. PubMed ID: 33108906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. All-stage targeted therapy for glioblastoma based on lipid membrane coated cabazitaxel nanocrystals.
    Wu S; Lu L; Zhou J; Ran D; Wang S; Xu Q; Xu W; Wang J; Liu Y; Xie C; Luo Z; Lu W
    J Control Release; 2022 May; 345():685-695. PubMed ID: 35346767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticancer drug candidate CBL0137, which inhibits histone chaperone FACT, is efficacious in preclinical orthotopic models of temozolomide-responsive and -resistant glioblastoma.
    Barone TA; Burkhart CA; Safina A; Haderski G; Gurova KV; Purmal AA; Gudkov AV; Plunkett RJ
    Neuro Oncol; 2017 Feb; 19(2):186-196. PubMed ID: 27370399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A highly potent CDK4/6 inhibitor was rationally designed to overcome blood brain barrier in gliobastoma therapy.
    Yin L; Li H; Liu W; Yao Z; Cheng Z; Zhang H; Zou H
    Eur J Med Chem; 2018 Jan; 144():1-28. PubMed ID: 29247857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cnf1 Variants Endowed with the Ability to Cross the Blood-Brain Barrier: A New Potential Therapeutic Strategy for Glioblastoma.
    Colarusso A; Maroccia Z; Parrilli E; Germinario EAP; Fortuna A; Loizzo S; Ricceri L; Tutino ML; Fiorentini C; Fabbri A
    Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32375387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Charge Conversional Biomimetic Nanocomplexes as a Multifunctional Platform for Boosting Orthotopic Glioblastoma RNAi Therapy.
    Liu Y; Zou Y; Feng C; Lee A; Yin J; Chung R; Park JB; Rizos H; Tao W; Zheng M; Farokhzad OC; Shi B
    Nano Lett; 2020 Mar; 20(3):1637-1646. PubMed ID: 32013452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Harnessing nanomedicine for therapeutic intervention in glioblastoma.
    Gutkin A; Cohen ZR; Peer D
    Expert Opin Drug Deliv; 2016 Nov; 13(11):1573-1582. PubMed ID: 27292970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Super-small zwitterionic micelles enable the improvement of blood-brain barrier crossing for efficient orthotopic glioblastoma combinational therapy.
    Wang K; Zhao B; Ao Y; Zhu J; Zhao C; Wang W; Zou Y; Huang D; Zhong Y; Chen W; Qian H
    J Control Release; 2023 Dec; 364():261-271. PubMed ID: 37839641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Advanced
    Chan MH; Chen W; Li CH; Fang CY; Chang YC; Wei DH; Liu RS; Hsiao M
    ACS Appl Mater Interfaces; 2021 Jun; 13(23):26759-26769. PubMed ID: 34076419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Facile synthesis of lactoferrin conjugated ultra small large pore silica nanoparticles for the treatment of glioblastoma.
    Janjua TI; Ahmed-Cox A; Meka AK; Mansfeld FM; Forgham H; Ignacio RMC; Cao Y; McCarroll JA; Mazzieri R; Kavallaris M; Popat A
    Nanoscale; 2021 Oct; 13(40):16909-16922. PubMed ID: 34533167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Initial contact of glioblastoma cells with existing normal brain endothelial cells strengthen the barrier function via fibroblast growth factor 2 secretion: a new in vitro blood-brain barrier model.
    Toyoda K; Tanaka K; Nakagawa S; Thuy DH; Ujifuku K; Kamada K; Hayashi K; Matsuo T; Nagata I; Niwa M
    Cell Mol Neurobiol; 2013 May; 33(4):489-501. PubMed ID: 23385422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain Co-Delivery of Temozolomide and Cisplatin for Combinatorial Glioblastoma Chemotherapy.
    Zou Y; Wang Y; Xu S; Liu Y; Yin J; Lovejoy DB; Zheng M; Liang XJ; Park JB; Efremov YM; Ulasov I; Shi B
    Adv Mater; 2022 Aug; 34(33):e2203958. PubMed ID: 35738390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent Advances on Surface-Modified GBM Targeted Nanoparticles: Targeting Strategies and Surface Characterization.
    Rodà F; Caraffi R; Picciolini S; Tosi G; Vandelli MA; Ruozi B; Bedoni M; Ottonelli I; Duskey JT
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood-brain Barrier Permeable and Multi-stimuli Responsive Nanoplatform for Orthotopic Glioma Inhibition by Synergistic Enhanced Chemo-/Chemodynamic/Photothermal/Starvation Therapy.
    Cao Y; Jin L; Zhang S; Lv Z; Yin N; Zhang H; Zhang T; Wang Y; Chen Y; Liu X; Zhao G
    Eur J Pharm Sci; 2023 Jan; 180():106319. PubMed ID: 36328086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles.
    Norouzi M; Yathindranath V; Thliveris JA; Kopec BM; Siahaan TJ; Miller DW
    Sci Rep; 2020 Jul; 10(1):11292. PubMed ID: 32647151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Locoregional Confinement and Major Clinical Benefit of
    Séhédic D; Chourpa I; Tétaud C; Griveau A; Loussouarn C; Avril S; Legendre C; Lepareur N; Wion D; Hindré F; Davodeau F; Garcion E
    Theranostics; 2017; 7(18):4517-4536. PubMed ID: 29158842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymeric nanoparticle mediated inhibition of miR-21 with enhanced miR-124 expression for combinatorial glioblastoma therapy.
    Liu Y; Zheng M; Jiao M; Yan C; Xu S; Du Q; Morsch M; Yin J; Shi B
    Biomaterials; 2021 Sep; 276():121036. PubMed ID: 34329919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amphetamine decorated cationic lipid nanoparticles cross the blood-brain barrier: therapeutic promise for combating glioblastoma.
    Saha S; Yakati V; Shankar G; Jaggarapu MMCS; Moku G; Madhusudana K; Banerjee R; Ramkrishna S; Srinivas R; Chaudhuri A
    J Mater Chem B; 2020 May; 8(19):4318-4330. PubMed ID: 32330214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.